Evaluating Flexible Modeling of Continuous Covariates in Inverse-Weighted Estimators.


Journal

American journal of epidemiology
ISSN: 1476-6256
Titre abrégé: Am J Epidemiol
Pays: United States
ID NLM: 7910653

Informations de publication

Date de publication:
01 06 2019
Historique:
received: 10 12 2017
revised: 27 12 2018
accepted: 07 01 2019
pubmed: 17 1 2019
medline: 11 2 2020
entrez: 17 1 2019
Statut: ppublish

Résumé

Correct specification of the exposure model is essential for unbiased estimation in marginal structural models with inverse-probability-of-treatment weights. However, although flexible modeling is commonplace when estimating effects of continuous covariates in outcome models, its use is less frequent in estimation of inverse probability weights. Using simulations, we assess the accuracy of the treatment effect estimates and covariate balance obtained with different exposure model specifications when the true relationship between a continuous, possibly time-varying covariate Lt and the logit of the probability of exposure is nonlinear. Specifically, we compare 4 approaches to modeling the effect of Lt when estimating inverse probability weights: a linear function, the covariate-balancing propensity score, and 2 easy-to-implement flexible methods that relax the assumption of linearity: cubic regression splines and fractional polynomials. Using data from 2 empirical studies, we compare linear exposure models with flexible exposure models to estimate the effect of sustained virological response to hepatitis C virus treatment on the progression of liver fibrosis. Our simulation results demonstrate that ignoring important nonlinear relationships when fitting the exposure model may provide poorer covariate balance and induce substantial bias in the estimated exposure-outcome associations. Analysts should routinely consider flexible modeling of continuous covariates when estimating inverse-probability-of-treatment weights.

Identifiants

pubmed: 30649165
pii: 5288096
doi: 10.1093/aje/kwz004
pmc: PMC6545287
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1181-1191

Subventions

Organisme : Canadian Institutes of Health Research
ID : MOP-81275
Pays : International
Organisme : Canadian Institutes of Health Research
ID : MOP-81275
Pays : International
Organisme : Canadian Institutes of Health Research
ID : MOP-130402
Pays : International
Organisme : CIHR
ID : FDN-143270
Pays : Canada
Organisme : CIHR
ID : CTN222
Pays : Canada

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Références

Epidemiology. 2017 Sep;28(5):e51-e53
pubmed: 28768302
CMAJ. 2013 Mar 19;185(5):401-6
pubmed: 23401401
J Rheumatol. 1998 Feb;25(2):277-84
pubmed: 9489819
JAMA. 2014 Feb 5;311(5):507-20
pubmed: 24352797
Comput Stat Data Anal. 2014 Apr;72:219-226
pubmed: 24587587
Stat Med. 2013 Sep 30;32(22):3788-803
pubmed: 23580422
Stat Med. 2014 Dec 30;33(30):5413-32
pubmed: 25074480
Am J Epidemiol. 2015 Jan 15;181(2):108-19
pubmed: 25515168
Stat Med. 2007 Jan 30;26(2):392-408
pubmed: 16479552
Biometrics. 2007 Jun;63(2):447-55
pubmed: 17688497
Am J Epidemiol. 2008 Sep 15;168(6):656-64
pubmed: 18682488
Am J Epidemiol. 1997 Apr 15;145(8):714-29
pubmed: 9125998
Epidemiology. 2000 Sep;11(5):550-60
pubmed: 10955408
Stat Med. 2013 Jun 15;32(13):2262-77
pubmed: 23034770
J Natl Cancer Inst. 1988 Oct 5;80(15):1198-202
pubmed: 3047407
Crit Care Med. 2017 Feb;45(2):225-233
pubmed: 27618277
Epidemiology. 2000 Sep;11(5):561-70
pubmed: 10955409
Stat Med. 2008 Aug 15;27(18):3629-42
pubmed: 18254127
Stat Med. 2009 Nov 10;28(25):3083-107
pubmed: 19757444
Stat Appl Genet Mol Biol. 2007;6:Article25
pubmed: 17910531
Epidemiology. 1995 Jul;6(4):356-65
pubmed: 7548341
Int J Biostat. 2010 Mar 03;6(2):Article 10
pubmed: 20648215
Hepatology. 2009 Apr;49(4):1335-74
pubmed: 19330875
Am J Epidemiol. 1987 Aug;126(2):310-8
pubmed: 3300281
Epidemiology. 2014 Mar;25(2):292-9
pubmed: 24487212
Int J Epidemiol. 2010 Oct;39(5):1162-9
pubmed: 19786463
Stat Med. 1989 May;8(5):551-61
pubmed: 2657958
Int J Epidemiol. 1999 Oct;28(5):964-74
pubmed: 10597998
Am J Epidemiol. 2005 Aug 15;162(4):382-8
pubmed: 16014771
Am J Epidemiol. 2016 Aug 1;184(3):249-58
pubmed: 27416840
Hepatology. 2003 Aug;38(2):518-26
pubmed: 12883497
Pharmacoepidemiol Drug Saf. 2015 Oct;24(10):1068-75
pubmed: 26265483

Auteurs

Ryan P Kyle (RP)

Department of Epidemiology, Biostatistics and Occupational Health, Faculty of Medicine, McGill University, Montréal, Québec, Canada.

Erica E M Moodie (EEM)

Department of Epidemiology, Biostatistics and Occupational Health, Faculty of Medicine, McGill University, Montréal, Québec, Canada.

Marina B Klein (MB)

Department of Epidemiology, Biostatistics and Occupational Health, Faculty of Medicine, McGill University, Montréal, Québec, Canada.
Department of Medicine, Division of Infectious Diseases and Division of Immunodeficiency, Royal Victoria Hospital, McGill University Health Centre, Montréal, Québec, Canada.

Michał Abrahamowicz (M)

Department of Epidemiology, Biostatistics and Occupational Health, Faculty of Medicine, McGill University, Montréal, Québec, Canada.
Division of Clinical Epidemiology, McGill University Health Centre, Montréal, Québec, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH